Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Safety of combination pharmaco...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Safety of combination pharmacotherapy in elderly patients

Safety of combination pharmacotherapy in elderly patients

The article reviews literature data on adverse reactions to drugs. The frequency of suspected adverse reactions in indoor patients over 60 years old is 2-3 times higher than that in patients younger than 30 years. This is due to peculiarities of drugs pharmacokinetics (absorption, distribution, meta...

Full description

Bibliographic Details
Main Authors: E. V. Shikh, A. D. Ismagilov, Zh. M. Sizova, O. A. Demidova
Format: Article
Language:Russian
Published: Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’) 2018-02-01
Series:Регуляторные исследования и экспертиза лекарственных средств
Subjects:
комбинированная фармакотерапия
взаимодействие лекарственных средств
пожилой возраст
цитохром р450
интервал qt
combination pharmacotherapy
drug interaction
elderly patient
p450 cytochrome
qt interval
Online Access:https://www.vedomostincesmp.ru/jour/article/view/117
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.vedomostincesmp.ru/jour/article/view/117

Similar Items

  • Clinical-pharmacological aspects of the safe use of medicines, causing prolongation of QT interval
    by: O. A. Demidova, et al.
    Published: (2018-02-01)
  • Determination of the activity of drug-metabolizing enzymes - the prospects for their use in clinical practice
    by: V. V. Smirnov, et al.
    Published: (2018-02-01)
  • Isoform CYP1A2, as a part of the cytochrome P450 superfamily
    by: Y. G. Novickaya, et al.
    Published: (2014-04-01)
  • The risk of milk thistle (<i>Silybum marianum</i>) drug interactions
    by: A. S. Kazakov, et al.
    Published: (2018-02-01)
  • CYP3A4 isoenzyme phenotyping for personalisation of pharmacotherapy
    by: E. A. Egorenkov, et al.
    Published: (2018-02-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs